7. “During the treatment period, patients taking Epidiolex 20mg/kg/day achieved a median reduction in monthly drop seizures of 42 percent compared with a reduction of 17 percent in patients taking placebo (p=0.0047), and patients taking Epidiolex 10mg/kg/day achieved a median reduction in monthly drop seizures of 37 percent compared with a reduction of 17 percent in patients taking placebo (p=0.0016).” This is a significant breakthrough when it comes to the medical marijuana treatment and that’s why we put it on the list of health benefits of medical marijuana according to publicly traded weed companies.
http://dev-gwpharma.pantheonsite.io/about-us/news/gw-pharmaceuticals-announces-second-positive-phase-3-pivotal-trial-epidiolex
racorn/Shutterstock.com
